Development of TLR9 agonists for cancer therapy
Arthur Μ. Krieg(Celldex Therapeutics (United States))
Cited by 428
Related Papers
Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo
|The Journal of Immunology|2000|586